Another Unprecedented OS Win in Extensive-Stage SCLC With Tarlatamab Maintenance
MedPage Today 6 views
Topic timeline
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
Earliest in tracked window
Oldest report in the coverage window currently tracked for this topic.
Subcutaneous tarlatamab shows favorable safety profile and antitumor activity in extensive-stage small cell lung cancer Medical Xpress · Sep 12, 2026Latest update
Most recent tracked report from MedPage Today.
Another Unprecedented OS Win in Extensive-Stage SCLC With Tarlatamab Maintenance MedPage Today · 1h ago4 reports in date order. Not enough independent coverage yet to show a development timeline.
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow